Archive | Managed care RSS feed for this section

Consumer engagement in health: greater cost-consciousness and demand for cost/quality information

People enrolled in consumer-directed health plans (CDHPs) are more likely than enrollees in traditional health insurance products to be cost-conscious. In particular, CDHP members check prices before they receive health care services, ask for generic drugs versus branded Rx’s, talk to doctors about treatment options and their costs, and use online cost-tracking tools. Furthermore, CDHP [...]

Read full story Comments { 1 }

Employers’ health plans look to behavior change, while accelerating the premium cost shift to employees

The new mantra for employers who sponsor health benefits is: “a healthy workplace leads to a healthy workforce.” Employers that sponsor health plans are now in the behavior change business, according to Aon’s 2011 Health Care Survey. Health plans are tightly focusing on wellness, motivating and sustaining positive personal health changes, with carefully designed incentives [...]

Read full story Comments { 2 }

No relief: medical costs will increase by double-digits again in 2011

Medical costs will grow between 10% and 11% in 2011, depending on whether an enrollee is opting for a PPO (11%), a POS (11.2%) or an HMO plan (10.2%). These growth rates are similar to 2010 increases, with the largest percentage growth projected for point-of-service plans from 10.6% in 2010 to 11.2% next year. These [...]

Read full story Comments { 2 }

Benefits and costs: the growing burden of health insurance on American families

Since 2000, American workers’ contributions to health insurance premiums more than doubled, to nearly $4,000 a year from $1,619 ten years earlier. The total premium going to health insurance per worker for family coverage is $13,770 in 2010, with nearly $10,000 being borne by the employer. Workers’ share of premium increased 147%, and employers’ grew 114%. The [...]

Read full story Comments { 0 }

Health consumers don’t understand their patient-power…yet

Most health consumers define the value of drugs in terms of safety and efficacy first, then quality of life and cost second. These priorities are similarly shared by both biopharma executives and managed care management. Where consumers diverge with the two health industry stakeholders, though, is with respect to their power: while about 1 in 3 [...]

Read full story Comments { 3 }